The Sol Goldman Pancreatic Cancer Research Center

What's New 2017

100 grants funded!

The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has reached a remarkable milestone! The Goldman Center just funded its 100th pancreatic cancer research grant! Beginning 2005, income from The Sol Goldman Pancreatic Cancer Research Center endowment has funded 100 grant proposals, benefiting 41 principal investigators from 16 departments exploring novel avenues of research. What remarkable impact!

Congratulations, Dr. Ralph Hruban!

Dr. Ralph Hruban, Director of the Sol Goldman Pancreatic Cancer Research Center was recently recognized by Clarivate Analytics as one of the world's most highly cited researchers ( This recognition is based on the number of citations for papers published between 2005 and 2015. Citations are when one researcher references another researcher's paper in their work. A wonderful indicator of the impact of the Goldman Center!

PanCAN Visit

PanCan Group 2017
The Baltimore and Washington D.C. affiliates of PanCAN, the national pancreatic cancer advocacy group, visited the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins on Sunday, November 12, 2017. The morning started with Dr. Ralph Hruban inviting the patients, family members, advocates and the Hopkins team to introduce themselves and share their connection to pancreatic cancer. The visitors then broke up into eight groups for small informal meetings with the doctors, scientists and health care providers at Hopkins. Each group spent 10-15 minutes with a member of the Hopkins team, and then moved to the next team member. Dr. Hruban described it as "speed dating!" Most importantly, the PanCAN visitors got a close-up and personal tour of the labs and the opportunity to meet and chat with a number of the world leaders in pancreatic cancer care and research. The team members from Hopkins who participated in the event included:

PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017
PanCan Meeting 2017


The Cancer Genome Atlas (TCGA) research network (the US government's effort to sequence the DNA in all of the major types of cancer), just published their results from a complete genetic analysis of 150 pancreatic cancers! In the August 14th issue of the journal CancerCell, the TCGA authors describe a detailed integrated (DNA, RNA and protein) analysis of the 150 pancreatic cancers. The major genes driving pancreatic cancer are described, and the authors identified two main subtypes of pancreatic cancer (basal-like/squamous and classical/progenitor). While this study does not have direct patient impact yet, it does represent a major milestone in our understanding of this disease. Special congratulations to the many scientists from Johns Hopkins who contributed to this study!

Cory Sandone and Carolyn Hruban created this medical illustration in honor of the study.

The Cancer Genome Atlas (TCGA) Research Network performed integrated genomic, transcriptomic and proteomic profiling of 150 pancreatic ductal adenocarcinomas (PDACs). PDACs (depicted as a star-shaped mass in the pancreas) are composed of a few neoplastic cells (marbles labeled with crabs) admixed with greater numbers of non-neoplastic cells (white marbles). The team employed a novel analytical strategy (depicted as the sieve) to identify neoplastic cell-specific molecular subgroups (depicted as the buckets of enriched populations of marbles with crabs).

Sol Goldman Professorship

Hruban, Goggins, & Rothman
A wonderful ceremony was held on Monday June 19th, establishing the Sol Goldman Professorship in Pancreatic Cancer Research in the Department of Pathology. This professorship honors the legacy of Sol Goldman and provides critical stability and flexibility to our faculty so that they can take advantage of important opportunities for innovative research. Michael Goggins, a world leader in the early detection of pancreatic cancer and long-term member of the Sol Goldman Pancreatic Cancer Research Center, was inducted as the first recipient of the Goldman Professorship. Congratulations Mike!

Pancreatic cancer patients may live longer by traveling to academic hospital for operation

A recent paper published in the Journal of the American College of Surgeons reports that traveling to an academic medical center such as Johns Hopkins for surgical resection of a pancreatic cancer is associated with higher quality surgical care. Although they found better care at high-volume surgical centers, they report that few patients travel for their cancer operations. To learn more, visit: or

Congratulations Dr. Weiss!

Dr. Matthew Weiss
Johns Hopkins pancreas surgeon Dr. Matthew Weiss was inducted into the Miller-Coulson Academy as a Miller-Coulson Scholar. This high honor recognizes clinical excellence- "The clinically excellent academic physician who has achieved a level of mastery in communication & interpersonal skills, professionalism & humanism, and negotiation of the healthcare system. Such physicians are exemplary with respect to diagnostic acumen, knowledge, and their scholarly approach to clinical practice. They exhibit a passion for patient care, and they explicitly model all of the above to medical trainees, earning them a reputation for being exceptional." Congratulations Dr. Weiss!